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Introduction
Important advances have been made in gene transfer technology, 
with current efforts focusing on the design of safer and longer-lasting 
delivery vectors, as well as systems possessing cell-type specificity and 
regulatable expression. The association of viral vector-based gene 
delivery with nanotechnology now offers the possibility to develop 
more efficient gene transfer strategies for a number of applications 
in vitro and in vivo [1]. In 1978, Widder KJ introduced the concept 
of Magnetic Drug Targeting (MDT) and described how magnetically 
responsive therapeutic complexes could be concentrated in target areas 
of the body by means of external gradient magnetic fields [2]. Later, 
in the early 2000s this principle was applied to the delivery of nucleic 
acids into cells and a magnetic field-assisted transfection methodology 
emerged named magnetofection [3].
Magnetofection is based on the association of magnetic nanoparticles 
(MNPs) with non-viral or viral vectors in order to optimize nucleic 
acid delivery into biological systems in the presence of a magnetic field. 
The resulting “magnetic vectors” have to biocompatible enough for 
applications in living cells and organism and their magnetic response 
has to be sufficient to allow concentration at the target area under the 
influence of a magnetic force [1]. The current availability of stable, 
versatile and nontoxic MNPs offers the possibility to implement them 
for different biomedical pourposes such as anti-neoplasic therapy thru 
controlled hyperthermia, cell sorting and separation, drug delivery, 
gene and cell therapy and Magnetic Resonance Imaging [4]. Detailed 
protocols for MNPs synthesis and their biophysical characterization 
have been extensively described in the literature [5-7] as well as the 
mechanism for cellular uptake and metabolism [8].
One of the most important features of MNP-based transfection 
is the abilility to access virtualy any cell type due to its receptor-
independent endocytic uptake. This is particularly useful in traditionaly 
hard-to-transfect and hard-to-transduce cells like NIH-3T3 fibroblasts 
[9], breast and mouse melanoma cancer cells [10], human peripheral 
blood lymphocytes [3] and mature skeletal muscle cells [11]. Skeletal 
muscle progenitors, called myoblasts, are mononucleated, mitoticaly 
active cells which divide rapidly until external cues signal them to 
exit the cell cycle and differentiate by fusing together into elongated, 
multinucleated myofibers (myotubes in vitro). It is well known that the 
skeletal muscle suffers a maturation-dependent loss of susceptibility 
to RAd uptake [12,13] which may represent a major constraint in the 
use of these vectors for gene transfer and therapy. It is believed that 
structural and biochemical changes are responsible for these decreased 
transduction efficiencies with adenoviral vectors. The entry of both 
wild and recombinant Adenovirus (Ad and RAd) into cells comprises 
a two-step sequence involving different membrane proteins: a high-
affinity primary receptor, the Coxsackievirus and Adenovirus Receptor 
(CAR), that mediates the attachment of virus to the cell surface, and 
lower-affinity secondary receptors (αvβ3 and αvβ5 integrins) that 
allow internalization of the viral particles [14,15] Several studies have 
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Abstract
The goal of magnetic field-assisted gene transfer is to enhance internalization of exogenous nucleic acids by 
association with magnetic nanoparticles (MNPs). This technique named magnetofection is particularly useful in difficult-
to-transfect cells. It is well known that human, mouse, and rat skeletal muscle cells suffer a maturation-dependent 
loss of susceptibility to Recombinant Adenoviral vector (RAd) uptake. In postnatal, fully differentiated myofibers, the 
expression of the primary Coxsackie and Adenoviral membrane receptor (CAR) is severely downregulated representing 
a main hurdle for the use of these vectors in gene transfer/therapy. 
Here we demonstrate that assembling of Recombinant Adenoviral vectors with suitable iron oxide MNPs into 
magneto-adenovectors (RAd-MNP) and further exposure to a gradient magnetic field enables to efficiently overcome 
transduction resistance in skeletal muscle cells. Expression of Green Fluorescent Protein and Insulin-like Growth 
Factor 1 was significantly enhanced after magnetofection with RAd-MNPs complexes in C2C12 myotubes in vitro and 
mouse skeletal muscle in vivo when compared to transduction with naked virus. These results provide evidence that 
magnetofection, mainly due to its membrane-receptor independent mechanism, constitutes a simple and effective 
alternative to current methods for gene transfer into traditionally hard-to-transfect biological models.
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shown that in developing human, mouse and rat muscle, expression 
of the primary Ad membrane receptor CAR is severely downregulated 
even at early ages with CAR mRNA being barely detectable in adult 
myofibers [16]. Furthermore, it has been demonstrated that forced 
expression of CAR in myotubes by different aproches overcomes the 
poor RAd-mediated transducibility of these cells [17,18]. On the other 
hand, basal lamina and glycocalyx surrounding mature skeletal muscle 
cells appear to be an anatomical barrier that may limit the access of 
exogenously introduced virus [19]. 
In order to understand the physiology and physiopathology of 
the skeletal muscle, it is sometimes required to manipulate the levels 
or type of genes expressing this tissue. Adult skeletal muscle could 
be transfected in vivo with a low efficiency by either direct injection 
of naked plasmids [20], cationic lipids and neutral polymers [11,21] 
or most efficiently by electroporation [22] an established technology 
that transiently permeabilizes cell membrane with an electrical pulse, 
allowing the uptake of a wide spectrum of biological molecules-. None 
of these techniques, however, has the potential displayed by viral 
vectors, which are a highly effective transfection tools at the myoblast 
level [23,24].
The present work focuses on circumventing the low RAd-
mediated transduction in differentiated skeletal muscle cells. Here we 
demonstrate the effective use of Magnetic nanoparticles-Recombinant 
Adenoviral vectors complexes (MNPs-RAd) to mediate transgene 
expression in mature C2C12 myotubes. We propose that MNPs-RAd 
represents a highly efficient method for transgene delivery in otherwise 
transfection-resistant differentiated skeletal muscle cells.
Materials and Methods
Myoblast and myotube cell cultures
C2C12 myoblasts (ATCC® Number CRL-1772) were grown in high-
glucose DMEM supplemented with 10% fetal calf serum (proliferation 
medium). When cells reached 70-80% confluence myoblasts were 
induced to differentiate and fuse into multinucleated myotubes by 
replacing the proliferation medium to DMEM with 2% donor horse 
serum (differentiation medium). After 6 days, multinucleated myotubes 
were infected for in vitro gene transfer protocol as described below. 
Chemicals were from Gibco® (Thermofisher, Carlsbad, CA, USA) and 
Sigma-Aldrich® (St Louis, MO, USA) and culture plates from Corning® 
(New York City, NY, USA).
Magnetic nanoparticles (MNPs) and magnetic field 
applicators
For formulation of the magnetic adenoviral complexes, the particles 
with a surface coating of 25-kDA branched polyethylenimine (PEI-
25Br) combined with the fluorinated surfactant ZONYL FSA (lithium 
3-[2-(perfluoroalkyl)ethylthio]propionate) were used, hereafter 
referred to as PEI-Mag2. [25] The aqueous MNP suspensions were 
sterilized using 60Co gamma-irradiation at a dose of 25 kGy. The MNP 
concentration was determined in terms of the iron content of the dry 
nanomaterial and the iron content in aqueous suspension of the stock 
nanomaterial as described previously [26]. The particles contain 560 mg 
Fe/g dry material weight. The mean iron oxide core size was calculated 
from the broadening of the X-ray diffraction peaks using the Scherrer 
formula. The static magnetic properties of the particles were evaluated 
by measuring the quasistatic magnetization in the applied DC-fields 
or M (H) by using the MPMS commercial susceptometer (Quantum 
Design, USA). Labeling of the PEI-Mag2 magnetic nanoparticles 
with a coating comprising PEI was performed using Atto550 NHS 
ester (Sigma-Aldrich®, Taufkirchen, Germany) in a 0.1 M Na-borate 
buffer, pH 8.5, followed by dialysis against water using a cassette 
dialysis device (Pierce Company, Dallas, Texas, USA) with a 3,500 
MW cutoff as described in detail in [27]. A commercial magnetic plate 
(Oz Biosciences®, Marseille, France) was used to provide the proper 
magnetic field required for magnetic sedimentation of the magnetic 
vector upon in vitro magnetofection. It is composed of cylindrical-
permanent-Nd-Fe-B magnets and generates a 0.3 T magnetic flux 
density and a gradient of 67-123T/m at a cell layer location. For in vivo 
magnetofection in C57BL/6 mice, a combination of two cylindrical 
magnets was used. After intramuscular administration of MNP-RAd-
complexes, the magnets were positioned directly over the mouse hind-
limb for 30 minutes, providing 430 mT of magnetic density at the 
surface of the magnet and a mean gradient of 18 mT/mm within the 
first centimeter.
Recombinant adenoviral vectors RAd-IGF1 and RAd-GFP
A recombinant adenoviral vector (RAd) harboring the rat IGF1 
gene (RAd-IGF1; IGF1 gene kindly donated by Dr. Peter Rotwein, 
Oregon Health Sciences University) was constructed in our laboratory 
by a variant of the 2-plasmid method [28] employing the AdMax 
plasmid kit (Microbix, Ontario, Canada). Briefly, the cDNA coding for 
the rat IGF1 gene (obtained from the mRNA for the IGF1b precursor 
form) [29] was excised from the plasmid pBluescript KS, subcloned in 
pCA14 and inserted into the multiple cloning site of shuttle pDC515, 
which contains an expression cassette consisting of the mouse 
cytomegalovirus promoter and the simian virus 40 polyadenylation 
signal, immediately upstream and downstream, respectively, of the 
multiple cloning site. The second plasmid from the kit, the genomic 
plasmid pBHGfrt(del)E1,3 FLP, consists of the entire genome of 
adenovirus 5, with deletions in the regions E1 and E3. In cotransfected 
HEK293 cells, FLP recombinase is readily expressed and efficiently 
catalyzes the site-directed recombination of the expression cassette of 
pDC515 into pBHGfrt (del) E1, 3 FLP, thus generating the genome of 
the desired vector RAd-IGF1. The newly generated RAd was rescued 
from HEK293 cell lysates and plaque purified. It was further purified 
by ultracentrifugation in CsCl gradient. Final virus stocks were titrated 
by a serial-dilution plaque assay. Another adenoviral vector, RAd-GFP, 
was constructed in our laboratory following the general procedures 
outlined above. It harbors a hybrid gene encoding the Aequorea 
victoria enhanced green fluorescent protein (GFP) driven by the mouse 
cytomegalovirus promoter. The vector was expanded in HEK293 cells 
and purified and titrated as for the RAd-IGF1 vector.
Self-assembled magneto-adenoviral vectors and in vitro gene 
transfer
For in vitro transduction, MNP-to-virus ratios of 1.5 and 2.5 
femtogramms of iron per Viral Physical Particle (VP), further referred 
to as fgFe/VP, were tested based on previous data on optimization of 
the magnetic adenoviral vectors [5]. Previous experiments revealed 
that a multiplicity of infection (MOI) of 60 viral particles per cell 
yielded a good infection rate in this cell line and therefore was selected 
for the transduction protocols. Magnetic adenoviral vectors (RAd-PEI-
Mag2) for in vitro transduction were assembled at MNP-to-virus ratios 
of 1.5 or 2.5 fgFe/VP by mixing PEI-Mag2 nanoparticle suspension 
containing 11.25 or 18.75 g Fe/mL phosphate buffered saline (PBS), 
respectively, with equal volume of the adenovirus dilution containing 
7.5 × 109 physical virus particles per mL DMEM without additives. 
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After incubation of the mixture for 20 minutes at room temperature 
to allow complex assembling the physic characteristics were measured. 
Myoblasts and myotubes were seeded on 24-well culture plates at a 
density of ≈1.2 × 105 cells/well resulting in about 250000 cells per well 
24 hours later upon infection. For transduction, 400 µl of the complexes 
(as prepared) were added to each well. As reference for later efficiency 
assessment, a naked virus dilution containing the same number of 
infective particles was used. Immediately after, the culture plate was 
positioned on top of the magnetic plate and exposed to the magnetic 
field for 30 min except for control cultures without magnet. After this 
incubation time, the magnetofection mixture was replaced with fresh 
cell culture medium.
In vivo magnetofection-based gene transfer
In vivo magnetofection was performed in 10-month old C57BL/6 
female mice. Magneto-adenovector RAd-Atto550PEI-Mag2was 
prepared at MNP-to-virus ratio of 4 fgFe/VP. For this, 9.8 µl of 
Atto550-PEI-Mag2 nanoparticle suspension containing 4.3 µg Fe were 
mixed with 0.2 µl of RAd-GFP adenovirus stock containing 109 physical 
virus particles (107 pfu) in sterile normal saline (0.9% NaCl). After 
incubation of the mixture for 20 minutes at room temperature to allow 
complex assembling, 10 µl of the complexes (as prepared) were injected 
into the Soleus muscle of mice as described below or diluted to 500 
µL normal saline and used for complex characterization. Animals were 
anesthetized with a mixture of Ketamine/Xylazine (90/10 mg/kg of 
weight) by ip route and positioned ventrally on the operating table with 
both hindlimbs extended and gently immobilized. The hair that covers 
the posterior and external region of both legs was removed, the skin 
disinfected with topic povidone-iodine and finally a 1-cm long incision 
was made to access the posterior muscular compartment. After delicate 
dissection of the fascia and connective tissue, the left Soleus muscle was 
identified and injected, in its middle portion, with 10 ul of magnetic 
adenoviral vector using a (Hamilton®) syringe. The muscle fascia and 
skin were immediately sutured and the entire hind-limb was exposed 
to an external magnetic field for 30 minutes (see section 2.2. for magnet 
details). The right, contralateral Soleus muscle served as control and 
was injected only with naked RAd-GFP adenoviral vector (107 pfu). 
Six days after magnetofection mice were euthanized by cervical 
dislocation. Muscles were promptly removed, fixed (4% PFA for 24 
hours at 4°C), cryopreserved by sucrose gradient (0.25 M sucrose in 
PBS for 1 h, 0.5 M sucrose in PBS for 45 min, and finally 1.5 M sucrose 
in PBS for 30 min), embedded in tissue-freezing medium (Cryoplast®, 
Biopack, Buenos Aires, Argentina) and snap frozen in liquid nitrogen. 
Tissue blocks were stored at -80°C. Longitudinal 20-μm thickness 
sections were obtained and mounted with fluorescent mounting 
medium (Fluoromount G™, Electron Microscopy Sciences, PA, USA). 
Slides were analyzed using a fluorescence microscope as described on 
section 2.6. All experimental work involving laboratory animals was in 
compliance with local (Comité Institucional para el Cuidado y Uso de 
Animales de Laboratorio, FCM, UNLP) and international guidelines. 
Characterization of the magneto-adenovectors 
The mean hydrodynamic diameter (Dh) and electrokinetic or 
ζ-potential of the MNPs and magnetic adenoviral complexes were 
determined by photon correlation spectroscopy (PCS) using a Malvern 
Zetasizer Nano Series 3000 HS (UK). Efficacy of the virus assembling 
with magnetic nanoparticles and stability of the complexes were 
assessed using iodine-127 labeled adenovirus as described in detail in 
ref. [5]. Briefly, Adenoviral particles were labeled with a iodine-127 as 
decribed were and assembled with PEI-Mag2 nanoparticles at different 
MNP-to-VP ratios in PBS for 30 min or further 1-to-1 diluted with 
Fetal Calf Serum, incubated for the next 30 and then exposed at the 
Magnetic Plate for 30 min, non-sedimented radioactivity was measured 
in a supernatant. To evaluate the rate of the magnetic vectors migration 
in applied gradient magnetic fields (magnetophoretic velocity) we 
have registered clarification kinetics of the suspensions by measuring 
space and time resolved extinction profiles using a customized 
(LUMiReader®) device equipped with a set of permanent magnets as 
described recently by Mykhaylyk et al. [30]. Concentration changes 
were detected by multiple extinction profiles taken at time intervals of 1 
s with a spatial resolution of 30 µm at an analytical optical wavelength of 
410 nm with Neodymium-Iron-Boron-Magnets positioned underneath 
the cuvette. From extinction profiles E is calculated averaged over a 
selected region of extinction profiles between meniscus and bottom 
of the cuvette and the relative extinction E/E0 was determined and 
plotted versus time, here E0 is an initial extinction of sample. In the 
linear range of Lambert-Beer law, the relative extinction Erel can be 
considered as a relative concentration and represents the rate of the 
complexes remaining in suspension. The efficient magnetophoretic 
velocity of particles was calculated as υ=<L>/t, here <L> is a mean 
path of the particles upon magnetophoresis. With a sample hight of 
8 mm (375 µl probe), <L>=4 mm.The relative concentration E/E0 
plotted against the magnetophoretic velocity υ represents a cumulative 
distribution function Ф(υ), which describes the particle ratio having a 
magnetophoretic velocity υι less or equal to the υι value. The median 
values of magnetic moment M of the complex and number of magnetic 
nanoparticles N=M/meff per complex/complex assembly were calculated 
as first described by Wilhelm et al. [31]. Here meff =8.7 × 10-20 Am2 
is an effective magnetic moment of the core of the nanoparticles 
accounting for the average diameter of the magnetite core of 9 nm and 
saturation magnetization of 62 emu/g iron.
Fluorescence image acquisition
Cell culture images were obtained using an Olympus® Digital 
Camera (E-330) attached to a Fluorescence Inverted Microscope 
(Olympus® IX71) with a 20 X objective lens (Olympus® Objective 
Lens LUCPLFLN 20XPH/NA 0.45). Tissue slides were analyzed with 
an Olympus Fluorescence Microscope (Olympus BX-51®; Olympus® 
Objective Lens Plan and UPlanFL N) equipped with a DP70 CCD 
Video Camera (Olympus, Tokyo, Japan). The subsequent image 
processing was performed with (Image-Pro® Plus) software (Version 
5.1.2, MediaCybernetics, Inc).
Quantitation of green fluorescent protein expression
Two days after transduction, the myoblasts and myotubes cultures 
were washed twice with PBS buffer and then incubated with 150 µl/
well of pre-cooled Lysis Buffer for 30 minutes at 4°C (0.1 % Triton 
X-100+EDTA 1 mM in PBS). The resulting lysates were spinned down 
at 13000 rpm during 2 minutes and the subsequent clean supernatants 
were aspirated and analyzed using a multimode microplate reader 
(Beckman Coulter, DTX 880 Multimode Detector) at excitation and 
emission wavelengths of 485/20 and 535/25 nm, respectively. To 
assure accurate comparison between gene delivery methods, unspecific 
fluorescence readings from cells alone, magnetic nanoparticles and 
lysis buffer were subtracted to the corresponding experimental group 
previous to data analysis. The results were expressed in Fluorescence 
Units.
IGF1 measurements
In order to quantitate the production of IGF1, supernatant from 
myotube cultures was collected 48 hs after viral transduction with or 
Citation: Pereyra AS, Mykhaylyk O, Lockhart EF, Taylor JR, Delbono O, et al. (2016) Magnetofection Enhances Adenoviral Vector-based Gene 
Delivery in Skeletal Muscle Cells. J Nanomed Nanotechnol 7: 364. doi:10.4172/2157-7439.1000364
Page 4 of 11
J Nanomed Nanotechnol
ISSN: 2157-7439 JNMNT, an open access journal
Volume 7 • Issue 2 • 1000364
without magnetofection and stored at -80°C until radioimmunoassay 
(RIA) was performed. IGF1 from samples was extracted by acid-
ethanol cryo-precipitation [32]. The recombinant human IGF1 
(rhIGF1, Chiron Corp., Emeryville, CA) was iodinated following 
the iodogen method [33]. The I125-labelled rhIGF1 was purified by 
exclusion chromatography on a PD-10 Sephadex G-25 M column (Cat. 
Num. 17-0851-01, GE Healthcare Bio-Sciences, PA, USA). The eluate 
corresponding to the rhIGF1 monomer was collected, the radioactivity 
was measured and then it was stored in aliquots at -20°C prior addition 
of glycerol. This material was used within 2 weeks of iodination and 
adjustments due to isotope decay were performed when necessary. The 
anti- rhIGF1 antibody (AFP4892898) was a gift from Dr A. F. Parlow 
(National Hormone and Peptide Program, Torrance, CA). Because 
the amino acid sequence of rat IGF1 differs from human IGF1 at only 
3 of 70 residues in positions 20, 35, and 67 [34] is feasible to detect 
rIGF1 using this anti-human antibody [35]. Goat anti-rabbit antiserum 
(second antibody) was obtained with assistance from the School of 
Agricultural and Forestry Sciences, National University of La Plata. 
Transmission electronic microscopy image acquisition
Myoblasts and myotubes were seeded on 12-well culture plates 
(2.4 × 105 cells/well). Viral transduction and magnetofection protocols 
were performed as described before. Once the incubation period was 
concluded, the RAd/RAd-MNPs mixtures were removed and the cell 
monolayer was fixed with 2% glutaraldehyde in phosphate buffer, (pH 
7.2-7.4) for 2 h at 4°C. The cells were mechanically detached and spin 
at 1500 rpm for 10 minutes. The cellular pellets were re-fixed with 
1% of osmium tetroxide for 1 h at 4ºC, dehydrated with ethanol and 
included in epoxy resin. Ultrathin slides (90 nm) were dye with uranyl 
acetate and lead-citrate and examined with a Transmission Electron 
Microscopy - JEM 1200 EX II (JEOL) (Electron Microscopy Core Lab, 
School of Veterinarian Medicine, National University of La Plata).
Statistical analysis
For each experimental group at least three replicate samples 
were performed. Results are presented as Mean ± Standard Error of 
the Mean. Analysis of differences between Means was conducted by 
Student’s t-test and one-way analysis of variance (ANOVA), followed 
by Student-Newman-Keuls test (Sigma Plot 11.2, Systat Software, 
San Jose, CA). An alpha value of p ≤ 0.05 was considered statistically 
significant.
Results
Preparation and characterization of magnetic nanoparticles 
and magneto-adenovectors
The physicochemical properties of the MNPs used to formulate 
magnetic adenoviral complexes have been extensively described 
elsewhere [5,6]. PEI-Mag2 are core-shell nanoparticles with an iron 
oxide core with an average magnetite core size of 9 nm, saturation 
magnetization of 62 emu/g Fe and a surface coating consisting of the 
fluorinated surfactant ZONYL FSA (lithium 3-[2-(perfluoroalkyl)
ethylthio] propionate) combined with 25-kDa branched poly-
ethyleneimine. This results in a zeta potential of +55.4 ± 1.6 mV in 
water. The particles conjugated with Atto550 (Atto-550-PEI-Mag2) 
contain on average 15 molecules of the dye molecules per insulated 
magnetic nanoparticle providing red fluorescence. The loading with the 
dye was chosen to ensure bright fluorescence of the particle/complexes 
in the cell and to keep high enough positive surface charge to stabilize 
the particles and enable association of the particles with the negatively 
charged adenoviral particles into magnetic vectors.
As shown in Figure 1, the amount of adenovirus that associated and 
magnetically sedimented with the PEI-Mag2 MNPs in PBS increased 
with increasing MNP-to-VP and amounted more than 90% of the 
initial virus particles at MNP-to-virus ratios of higher than 1 fg Fe/VP. 
When the formed complexes were incubated in 50% FCS for 30 min, 
partial destabilization of the adenovirus-MNP complexes occurred, 
however up to 60% of the adenovirus was still magnetically sedimented 
with PEI-Mag2 nanoparticles. Based on these results as well as on our 
previous data on optimization of the magnetic adenoviral vectors [5] 
the complexes for in vitro transduction were assembled at MNP-to-
virus ratios of 1.5 and 2.5 fgFe/VP and for in vivo experiments a ratio of 
4 fgFe per VP was used. The magneto-adenoviral vectors all possessed 
positive electrokinetic potential with a mean hydrodynamic diameter 
of 601, 521 and 937 nm, respectively (Table 1).
The data on clarification of the complexes suspension when 
subjected to a defined gradient field (shown in terms of the relative 
extinction E/E0 at 410 nm plotted vs. time, Figure 1 left) were plotted 
against the magnetophoretic velocity υ (Figure 2 right) to give a 
cumulative velocity distribution function Ф(υ). As complexes did 
not show detectable sedimentation under only gravity as can be 
seen from the plots “no filed” in Figure 2 left, the Ф(υ) describes the 
particle ratio having a magnetophoretic velocity υι less or equal to the 
υι value. The derived median magnetophoretic values υ 0.5 for the three 
viral complexes and the correspondent median values of magnetic 
moment M of the complex and number of magnetic nanoparticles N 
per complex/complex assembly are given in Table 1. The results suggest 
that there are multiple nanoparticles surrounding viral particles. 
Conventional gene delivery protocol with naked adenoviral 
vectors yields low efficiency in C2C12 myotubes
In order to determinate the transduction efficiency of C2C12 cell 
cultures by conventional Recombinant Adenoviral vector-based gene 
delivery, myoblasts and myotubes (6 days in differentiation medium) 
were incubated with RAd-GFP at a ratio of 60 infective viral particles 
per cell (MOI 60) and fluorescence microscopy images were taken 48 
hours later. The number of transduced, GFP-positive myotubes (Figure 
2, panel A2), as well as their fluorescence intensity, appeared lower 
when compared to images from myoblasts (Figure 2, panel A1).
Further quantitation of GFP levels was performed in cell lysates and 
expressed in absolute and relative Fluorescence Units (Figure 2B and 
Complex MNPs-to-VP ratio (fg Fe/VP) ξ (mV) Dh(nm) t0.5 (s) υ0.5 (µm/s) M (10-15 Am2) N=M/meff
RAd-PEI-Mag2 1.5 +11.4 ± 1.1 601 154 26 3.9 4.8E+04
RAd-PEI-Mag2 2.5 +10.2 ± 0.5 521 168 24 3.1 3.8E+04
RAd-Atto550-PEI-Mag2 4 +12.1 ± 0.2 937 22 184 43.2 5.2E+05
Table 1: Characteristics of the magnetic adenoviral vectors assembled at different MNP-to-VP ratios. After applying a magnetic flux density and field gradient of 0.16 T 
and 33.5 T/m, respectively, the following parameters were measured: electrokinetic or ξ-potential, intensity weighted mean hydrodynamic diameter Dh, time for magnetic 
separation of 50% of the complexes t0.5, median values of the magnetophoretic mobility υ0.5, magnetic moment M of the complex and number of magnetic nanoparticles N 
per complex/complex assembly. Meff=effective magnetic moment of the core of the nanoparticles accounting for the average diameter of the magnetite core of 9 nm and 
saturation magnetization of 62 emu/g iron.
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B’). As expected, a significantly inferior (p<0.05) reading was obtained 
in transduced C2C12 myotubes compared to myoblasts at the same 
viral MOI (22487.7 ± 1599.2 and 38139.2 ± 2790.9 fluorescence units 
respectively), which stresses the need for new strategies to improve 
gene transfection into mature skeletal muscle. 
Magnetofection enhances viral vector-mediated gene 
delivery efficacy in C2C12 myoblasts and myotubes
Here, we compared the efficacy of conventional RAd-based 
transduction protocol against magnetofection. Myoblasts and 
myotubes were incubated with either naked RAd-GFP or RAd-
GFP+MNPs complexes as described before. PEI-Mag2 nanoparticles 
were chosen and tested at two different fgFe per Viral Particle (fgFe/VP) 
ratios. All cultures were exposed to the magnetic field for 30 minutes 
and additional incubation without magnet was performed for another 
30-minute period. Afterwards, the transfection/magnetofection 
mixtures were removed (Figure 3). Images of transduced myoblasts 
(Figure 4, upper panel) and myotubes (Figure 4, lower panel,) were 
obtained 2 days later, and the quantitation of the fluorescence signal 
was subsequently performed. The use of RAd-MNPs complexes 
under the influence of a magnetic field achieved significantly higher 
transduction efficiency when compared to conventional protocol with 
naked RAd (p<0.05 for both experimental groups). For magnetofected 
myoblasts, the GFP levels were 5.9- and 12.8-fold higher with the use 
of 1.5 and 2.5 fgFe/VP respectively (Figure 3B and B’). In the case of 
C2C12 myotubes, incubation with RAd-GFP+PEIMag2 complexes 
had a 7.1- (at 1.5 fgFe/VP) and 23.6-fold (at 2.5 fgFe/VP) enhancing 
effect (Figure 4C and C’).
Since skeletal muscle tissue is frequently used as an ectopic 
production site for several secretion molecules with paracrine and 
endocrine functions we decided to evaluate whether magnetofection 
could enhance IGF1 production and secretion in vitro. C2C12 
myotubes were incubated with naked RAd-IGF1 or RAd-IGF1+PEI-
Mag2 complexes as described before for RAd-GFP and 48 hours later 
IGF1 levels were measured by RIA in the cell culture supernatant. In 
the magnetofected myotubes, there was a 4.3-fold increase (p<0.001) 
in the secreted levels of IGF1 when compared to naked virus (Figure 
4D and D’). 
Magnetofection achieves higher and more sustained levels of 
secreted IGF1 when compare to viral vectors alone
In a subset of C2C12 myotubes incubated with either RAd-IGF1 
alone or RAd-IGF1+MNPs complexes, a short time course analysis 
of IGF1 expression was performed. Transduction efficiency was 
determined by measuring IGF1 levels in cell culture medium at days 2, 
4 and 6 after gene delivery.
As shown in Figure 4E and E’, there was a significant initial 
overexpression of IGF1 peptide in both experimental groups when 
compared to basal levels from control, non-infected myotubes (1.98- 
and 7.27-foldfor naked RAd-IFG-1 and RAd+PEIMag2 respectively; 
*p<0.05). However, magnetofection was 3.3- to 5.9-fold more efficient 
(#p<0.05) than conventional naked RAd-mediated transduction at each 
time point. By day 6, secreted IGF1 from virally transduced myotubes 
had returned to basal levels while the concentration determined for the 
magnetofection-treated group remained considerably elevated (# p<0.05).
The magnetic field is a major component of magnetofection-
based gene delivery
Several literature reports suggested that MNPs could influence 
gene delivery even in the absence of a magnetic field (see Discussion 
for more details). To compare the efficacy of magnetofection with and 
without magnet the following experiment was performed. 
C2C12 myoblasts (Figure 5A and A’) and myotubes (Figure 5B 
and B’) were incubated with RAd-GFP+MNP complexes as described 
before and then placed over the magnetic plate for 30 minutes, except 
for the non-magnet group. A subset of cells were transduced only 
Figure 1: Magnetic nanoparticles and magnetic vectors: (A) Transmission 
Electron Microscopy image of the PEI-Mag2 nanoparticles, bar=5 nm. (B) 
Percent of the magnetically sedimented viral particles vs. MNP-to-Virus ratio 
(fg Fe/VP). Adenoviral particles labeled with a iodine-127 were assembled 
with PEI-Mag2 nanoparticles at different MNP-to-VP ratios in PBS for 30 
min (curve “PBS”) or further 1-to-1 diluted with Fetal Calf Serum, incubated 
for the next 30 and then exposed at the Magnetic Plate for 30 min (curve 
“50%FCS”), non-sedimented radioactivity was measured in a supernatant. 
(C and D) Magnetophoretic mobility of the magnetic vectors characterized 
by kinetics of clearance of the suspensions in applied gradient magnetic 
fields. Figure (C) shows extinction profiles at 410 nm for the suspensions 
of the magnetic adenoviral complexes registered with a customized 
LUMiReader® device with 2 disk magnets positioned underneath optical 
cuvette at multiple points along the vertical axis of the cuvette (STEP-MAG 
measurements). Schematics at the right panel shows an optical cuvette and 
a set of Neodymium-Iron-Boron-Magnets positioned underneath the cuvette; 
resulting magnetic flux density and gradient averaged over vertical sample 
height were of 0.16 T and 33.5T/m, respectively. (D) Normalized integral 
Extinction at 410 nm, E/E0, averaged through the probe height versus 
time upon exposure to magnetic field (MF on) or with no filed applied (no 
field) and derived data on cumulative distribution functions of the effective 
magnetophoretic mobility F(u). 
Citation: Pereyra AS, Mykhaylyk O, Lockhart EF, Taylor JR, Delbono O, et al. (2016) Magnetofection Enhances Adenoviral Vector-based Gene 
Delivery in Skeletal Muscle Cells. J Nanomed Nanotechnol 7: 364. doi:10.4172/2157-7439.1000364
Page 6 of 11
J Nanomed Nanotechnol
ISSN: 2157-7439 JNMNT, an open access journal
Volume 7 • Issue 2 • 1000364
Cellular uptake of RAd-MNPs complexes after magnetically-
induced sedimentation
The uptake and intracellular trafficking of RAd-MNPs complexes 
were visualized at different time points using Transmission Electron 
Microscopy (TEM). The iron core of the PEI-Mag2 magnetic 
nanoparticles provides the sufficient electron-density to allow tracking 
without further processing or labeling of the sample. Within 15 
minutes of exposure to the magnetic field, the magneto-adenovectors 
were scattered over the surface of C2C12 myotubes (Figure 6A1) and 
different engulfment processes seemed to become simultaneously 
activated. Several membrane protrusions (Figure 6A2-A4 red arrows) 
and invaginations (Figure 6A5, blue arrows) were already noticeable. 
At minute 30, endosome-like structures clearly started to form in the 
subcortical region of the cells (Figure 6B) and after 60 minutes, the 




































































Figure 2: Conventional gene delivery with naked adenoviral vectors yields 
low efficiency in c2c12 myotubes: C2C12 myoblasts and fully differentiated 
myotubes were incubated for 60 minutes with a recombinant adenoviral vector, 
RAd-GFP, at a MOI of 60 viral particles per cell. To assess GFP expression, 
cell culture imaging and fluorescence quantitation were performed 48 hours 
after infection. A Representative microscopy images of myoblasts (left) and 
myotubes (right) transduced with RAd-GFP. After image acquisition, GFP 
quantitation was performed in cellular lysates. Comparison between both 
groups was plotted as absolute B and relative-to-myoblasts fluorescenceB’. 
Unspecific fluorescence readings from cells alone and lysis buffer were 
subtracted to each group previous to data analysis. 
* Statistically significant difference with p < 0.05 between the experimental 
groups. Data values represent mean ± S.E.M. n=3 for each group. 
Magnification, 10X.
Figure 3: Magnetofection in cell culture: This illustration shows the general 
workflow for in vitro magnetofection. The RAd-MNP complexes are pre-
assembled in the test tube and later introduced to the cell culture in a dropwise 
manner. The culture plate is then exposed to a magnetic field created by the 
magnetic plate placed under it and 48 hours later.
Figure 4: Magnetofection enhances viral vector-mediated gene delivery in 
C2C12 myoblasts and myotubes: C2C12 myoblasts and fully differentiated 
myotubes were incubated with either naked recombinant adenoviral vectors 
(RAd-GFP or RAd-IGF-1) or RAd+MNPs complexes (RAd+PEIMag2) 
and exposed to an optimal magnetic field for 30 minutes. To assess gene 
delivery efficiency, GFP expression was evaluated using microscopy imaging 
and fluorescence quantitation 48 hours after infection for both groups. In 
a similar manner, IGF-1 levels were measured in the culture medium by 
radioimmunoassay. A Representative microscopy images of myoblasts 
(upper panels) and myotubes (lower panels) infected with RAd-GFP and RAd-
GFP+MNPs at 1.5 and 2.5 fgFe/VP MNP-to-Viral Particle ratios. After imaging, 
cells lysates were used to perform quantitation of GFP expression. Comparison 
between conventional viral transduction and magnetofection was plotted as 
absolute B and C and relative-to-naked virus fluorescence levels B’ and C’. 
Unspecific signal from cells alone, MNPs and lysis buffer were subtracted 
to each group previous to data analysis. To assess magnetofection efficacy 
with RAd-IGF-1, culture medium from myotubes was collected 48 hs after 
gene transfer protocols and processed for IGF-1 extraction and quantitation. 
Comparison between conventional viral transduction and magnetofection was 
plotted as absolute D and relative-to-naked virus concentration D’. IGF-1 basal 
levels in myotubes alone, as well as unspecific readings from extraction buffer, 
were subtracted to both experimental groups in order to show only viral vector-
mediated IGF-1 production. In a subset of myotubes, IGF-1 expression was 
analyzed in the culture medium at days 2 (D2), 4 (D4) and 6 (D6) after gene 
delivery and compared between non-infected, transduced with naked virus and 
magnetofected cells. Plots show absolute E and relative-to-myotubes alone E’ 
IGF-1 levels for each time point.
 *Statistically significant difference with p < 0.05 between non-infected myotubes 
and naked virus or magnetofection groups. #Statistically significant difference 
with p < 0.05 between naked virus and magnetofection groups. Data values 
represent mean ± S.E.M. n=3 for GFP groups, n=4 for IGF-1 at 48 hs and n=6 
for IGF-1 longitudinal analysis.  fgFe/VP=femtograms of iron per Viral Particle
with naked RAd-GFP and served as reference group for comparison 
between techniques.
As predicted, a slightly but significant 1.13- to 2.71-fold increase in 
GFP expression was observed when the magneto-adenovectors were 
administer even in the absence of a magnetic field (*p<0.05). However, 
the magnetically-driven incorporation of RAd-MNP complexes into 
the cells substantially enhanced this effect when compared to no-
magnet group (#p<0.05) and to naked virus (*p<0.05). Similar results 
were obtained with RAd-IGF1 (data not shown). 
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analysis of 20 μm-slides uncovered that injection of naked RAd-GFP 
resulted in transduction of only mononucleated cells with no Green 
Fluorescent Protein positive myofibers (Figure 8C1 and C2), similar 
to our in vitro results. The application of RAd-MNPs complexes 
driven by a magnetic field enhanced the transduction process allowing 
the entrance of RAd-GFP into the mature muscle fibers. Figure 8 
(panels D1-D4) shows GFP+myofibers after being magnetofected. 
As discussed also in section 3.6., due to the fluorescent properties of 
Atto550-PEI-Mag2 nanoparticles (visualized in red), it was feasible 
to evaluate their distribution and co-localization with GFP inside the 
Soleus muscle (Figure 8D5 and D6). It is worth noticing that, although 
magneto-adenovectors were able to successfully transduce mature 
myofibers, many complexes remained clustered nearby the muscle 
surface (Figure 8D1, white arrows). This strengthens the need for 
further experimentation and improvement.
Discussion 
Magnetofection has been successfully applied in vitro to many 
biological systems and cell lines that are traditionally consider hard to 
transduce with adenoviral vectors like NIH-3T3 mouse fibroblasts and 
rat glioma cells [9], breast (MCF7) and mouse melanoma (B16F10) 
cancer cells [10], primary human peripheral blood lymphocytes 
Figure 5: The magnetic field is a critical component of magnetofection-based 
gene delivery: C2C12 myoblasts and fully differentiated myotubes were 
incubated with either naked RAd or RAd+MagneticNanoParticles complexes 
and 48 hours later GFP expression was evaluated as described before. With 
and without magnetic field comparison was performed for both, myoblasts and 
myotubes. Results are plotted as absolute (A and B) and relative-to-naked virus 
fluorescence (A’ and B’). Unspecific fluorescence readings from cells alone, 
MNPs and lysis buffer were subtracted to each group previous data analysis. 
*Statistically significant difference with p < 0.05 between naked RAd and 
magnetofection with and without magnet. #Statistically significant difference 
with p < 0.05 between magnetofection with and without magnet. Data values 
represent mean ± S.E.M. n=3 for each group. 
fgFe/VP=femtograms of iron per Viral Particle
into cytoplasmic vesicles (Figure 6C). In some cases it was feasible to 
observe nearby the cell surface or attached to it, adenoviral particles 
surrounded by PEI-Mag2 nanoparticles (Figure 6D, green arrows).
The usage of magneto-adenovectors assembled with fluorescent 
MNPs (Atto500PEI-Mag2) allowed direct and simultaneous 
visualization of GFP expression (codified by the viral genome) and 
nanoparticle localization. As shown in Figure 7A and A’, 48 hours 
after magnetofection, green and red fluorescence colocalized within 
the same myoblasts. While GFP showed homogeneous cytoplasmatic 
distribution, signal from MNPs revealed a punctate and predominant 
perinuclear localization. Similar findings are reported here for C2C12 
myotubes (Figure 7B and B’) were this intracellular disposition of 
Atto550PEI-Mag2 is clearly observed around each nuclear domain.
In vivo magnetofection in mouse skeletal muscle
Our magnetofection protocol was evaluated in adult C57BL/6 mice. 
As described before, a minor surgical procedure was performed in 
both hindlimbs in order to access the Soleus muscle and achieve direct 
intramuscular delivery (Figure 8A). The right hindlimb was transduced 
only with viral vectors and served as control whereas the left Soleus was 
treated with magneto-adenovectors and exposed to a magnetic field. 
Six days later mice were euthanized and muscles removed. Observation 
of the freshly isolated Soleus revealed a large, brown area beneath the 
muscle surface where the RAd-MNPs were injected and mobilized 
due to magnetic forces (Figure 8B1-B3). Fluorescence microscopy 
Figure 6: Cellular uptake of RAd-MNPs complexes after magnetically-induced 
sedimentation: Magnetofection protocol was applied to fully differentiated 
C2C12 myotubes and Transmission Electron Microscopy (TEM) images were 
taken at different time points after magnetic-field exposure. (A1) 15 minutes after 
magnetic-field exposure. Lower-magnification image to show the highly electron-
dense (black) RAd-MNPs complexes distributed over the cell surface after 
magnetically-induced sedimentation. (A2–A5) Red arrows indicate membrane 
protrusions (lamellipodia-like structures) and blue arrows indicate membrane 
invaginations (pits). (B) After 30 minutes, engulfment and internalization of the 
RAd-MNPs complexes was evident (orange arrows). (C) 60 minutes after initial 
magnetic-field exposure, complexes could be visualized inside the cells, loaded 
into cytoplasmic vesicles (orange arrows). (D) Green arrows point to adenoviral 
particles surrounded by PEI-Mag2 magnetic nanoparticles while being engulfed 
by the myotube. Inset in the lower-right corner shows isolated Recombinant 
Adenoviral Vectors.
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characterization of RAd-MNPs interaction showed that the efficiency 
of complex formation in the absence of serum depends mainly on 
the relative amounts of MNPs and viral particles (VP). Therefore, we 
selected for our experiments MNP-to-VP ratios of 1.5 and 2.5 fgFe/
VP that were reported to achieve 75-80% of complex formation as 
measured by magnetically-driven sedimentation of the adenoviral 
particles [5].
RAd-GFP+PEIMag2-mediated infection of C2C12 myotubes in the 
presence of a magnetic field highly increased GFP expression up to 23-
fold compared to conventional RAd-GFP procedure. These results also 
demonstrate that conjugation of RAd with MNPs has no deleterious 
effect upon the overall performance of the recombinant adenovirus as 
gene delivery vector. Similar results were obtained in C2C12 myoblasts 
were GFP levels were up to 13-fold higher.
Since skeletal muscle is often selected as an ectopic production 
site for secretion molecules with paracrine-endocrine functions 
[37] or antigenic properties (vaccines) we evaluated the potential of 
magnetofection as delivery method for IGF1 transgene into C2C12 
myotubes. After incubation with RAd-IGF1+PEIMag2 and exposure 
to the magnetic field, the levels of secreted IGF1 growth factor into the 
culture medium were 4-fold higher than the ones achieved with naked 
A A’ 
B B’  
Figure 7: Intracellular fate and localization of RAd-MNPs complexes: To allow 
intracellular visualization and tracking, magnetoadenovectors were assembled 
with fluorescent MNPs and applied to C2C12 myoblasts and myotubes. 
Images were taken 48 hours afterwards. (A) simultaneous visualization of 
Green Fluorescent Protein expression (codified by the viral genome) and 
Atto550PEI-Mag2 nanoparticles (red fluorescence) in myoblasts. (A’) Enlarged 
area focused on the punctate, perinuclear localization of the red fluorescence. 
(B) Fully differentiated myotubes also displaying Atto550PEI-Mag2 localization 
around each nuclear domain. (B’) Enlarged picture of magnetofected myotubes.
(PBL16) [3] and human pancreatic carcinoma cells (EPP85-181RDB) 
[5]. Akiyama and collaborators [36] evaluated the expression of 
vascular endothelial growth factor (VEGF) in a monolayer of mouse 
C2C12 myoblasts using magnetofection with magnetite cationic 
liposomes (MCLs) coupled to a retroviral vector. This protocol 
increased transduction efficiency by approximately 7-fold compared 
with conventional retroviral method. 
Despite these many studies, the effectiveness of magnetofection in 
fully differentiated, mature myotubes has not been evaluated heretofore. 
Our results demonstrate that conjugation of recombinant adenoviral 
vectors (RAd) with iron oxide based-magnetic nanoparticles (MNPs) 
can circumvent the low infection rate of myotubes and significantly 
enhance adenoviral vector-mediated gene delivery into mature muscle 
cells.
First, we described how transduction of fully differentiated C2C12 
myotubes with naked RAd-GFP yield significantly lower transgene 
expression when compared to transduced myoblasts under the same 
conditions. This is in agreement with the well documented loss of 
the cell surface receptor CAR upon skeletal muscle maturation and 
differentiation [16]. 
Since magnetofection relies on membrane receptor-independent 
mechanisms for cell entry [3] we decided to test whether conjugation 
of RAd-GFP and RAd-IGF1 with poly-ethyleneimine-coated MNPs 
(PEIMag2) could improve gene transfer to skeletal muscle cells 
when exposed to a magnetic field. As mentioned before, the negative 
electrokinetic potential of adenoviral particles in aqueous media 
allows their assembly with cationic species of MNPs like PEI-coated 















Figure 8: In vivo magnetofection in mouse skeletal muscle: (A) Our 
magnetofection protocol was evaluated in 10-month old C57BL/6 mice. Animals 
were anesthetized and positioned ventrally on the operating table with both 
hindlimbs extended and gently immobilized. Finally a 1-cm long incision was 
made to access the posterior muscular compartment. (B1, B2 and B3) Six days 
after magnetofection, freshly isolated Soleus revealed a brown area beneath 
the muscle surface where the RAd-MNPs were injected. (C1 and C2) Naked 
RAd-GFP resulted in transduction of only mononucleated cells with no GFP 
positive myofibers. (D1-D4) After magnetofection with RAd-MNPs complexes, 
GFP positive myofibers were noticeable and clearly differ from the surrounding 
tissue auto fluorescence. (D5 and D6) Co-localization of GFP expression and 
magnetic nanoparticles (Atto550PEI-Mag2 with red fluorescence) within the 
same myofiber.
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RAd-IGF1. Considering that IGF1 synthesis and exocytosis are highly 
organized, energy-dependent processes [29] these results indirectly 
suggest that cell viability was not compromised during magnetofection.
It has been reported in the literature that MNPs can influence 
the cellular uptake of gene delivery vectors even in the absence of a 
magnetic field [5,38]. Here, we describe for C2C12 myoblasts and 
myotubes, a slightly but significant increase (1.13- to 2.71-fold) in 
transduction effectiveness of RAd-GFP+PEIMag2 complexes without 
magnet exposure over naked RAd-GFP. This could be explained by 
spontaneous, non-magnetically assisted sedimentation of magneto-
adenovectors over the cell monolayer due to their larger size compared 
to viral particles alone. The accumulation of complexes in close 
contact with the plasmatic membrane triggered their internalization 
and further transgene expression. Nevertheless, comparison of no-
magnet versus magnet groups demonstrated that the magnetic field is a 
major component of magnetofection since exposure to it significantly 
increased transduction of C2C12 muscle cells. This was probably due 
to more extensive sedimentation and enhanced cellular uptake of RAd-
MNPs complexes. 
Cellular uptake of nanoparticles (NPs) is mediated by different 
types of endocytosis taking place simultaneously within the same cell 
[8,39-41]. Selective blockage of the different internalization pathways 
in macrophage-like RAW264.7 cells revealed that dimercaptosuccinic 
acid-coated superparamagnetic iron oxide nanoparticles (DMSA-
SPIONs) are internalized by clathrin- and caveolin-mediated 
endocytosis (CME) as well as macropinocytosis, a receptor-
independent type of internalization [39]. Reports in C2C12 myoblasts 
showed that silica-based nanoparticles enter the cells mainly by CME 
and this correlated directly with high levels of transgene expression 
and therefore with overall transfection efficiency [40]. Similar results 
were obtained in human melanoma cells, human mesothelial cells and 
mouse fibroblasts exposed to silica-coated MNPs [38]. Internalization 
of PEI-coated MNPs, analogous to the ones used in our study, was 
thoroughly characterized in cultures of COS-7, SPC-A1, HeLa, 
HEP-G2 and BEAS-2B cells showing that they follow the same 
endocytic pathways [42,43]. Our TEM images from C2C12 myotubes 
incubated with RAd+PEIMag2 in the presence of a magnetic field 
showed perturbations of the cell surface that resemble internalization 
processes like the ones described above. Shortly after exposure to the 
magneto-adenovectors, protrusions of the cell plasma membrane to 
the external milieu like lamellipodia and ruffles and, at a lower extent, 
membrane invaginations (pits) started to form. These structures could 
be indicative of active macropinocytosis and CME. At a later time 
point (60 min), complexes could be visualized inside the cells, loaded 
into cytoplasmic vesicles, most likely to represent macropinosomes or 
early endosomes. It is worth noticing that, as reported in the literature 
[44], a correlation seemed to exist between the size of the RAd-MNPs 
aggregates and the internalization pathway, since macropinocytosis 
structures were more frequently observed engulfing large clusters.
We further analyzed the intracellular fate of magneto-adenovectors 
assembled with fluorescent MNPs (Atto500PEI-Mag2) which allowed 
us to simultaneously visualized GFP expression (codified by the 
viral genome) and nanoparticle localization. Forty-eight hours after 
magnetofection protocol, clusters of free MNPs and/or unassembled 
RAd-MNPs complexes displayed a predominant punctate pattern with 
perinuclear localization, consistent with the proposed internalization 
mechanisms and the classical centripetal distribution of internalized 
vesicles during the late stages of endosome-lysosome pathway. 
Similar findings were described in C2C12 myoblasts transfected with 
Rhodamine Red-labeled polyplexes that combine linear PEI substituted 
with histidine residues (His-PEI), were a perinuclear punctate pattern 
was observed after endocytosis [45]. Other formulations of NPs like 
magnetic polylactide-based coated with PEI [46], Boltorn-H30-
co-(PEG10k)5-Fluorescent [47] poly(lactic-co-glycolic) acid-PEI-
Hyaluronan [48] and magnetic polyacrylic acid-coated [49] also 
showed perinuclear localization after cellular uptake.
Despite the cell entry mechanism, any efficient gene delivery 
vector must be able to escape the endosome-lysosome pathway 
before degradation occurs. Moreover, those systems that do perform 
“endosomal escape” seem to achieve higher efficiency than direct 
cytosolic delivery (microinjection or electroporation) or formulations/
organisms unable to induce endosome-lysosome rupture [50,51]. In 
the case of wild type adenovirus and recombinant adenoviral vectors, 
interaction with the specific surface receptor (CAR) triggers clathrin-
mediated endocytosis followed by endosomal escape, cytoplasmic 
transport and DNA import to the nucleus. Simultaneously, 
macropinocytosis is induced by the presence of viral particles in the cell 
surface, thus, enhancing viral uptake and release into the cytosol [52,53]. 
A similar scenario to avoid lysosome degradation has been described 
for many different nucleic acid-NPs complexes, especially PEI-coated 
formulations [54-56]. The “proton-sponge” theory [57] describes how 
polyamines, like PEI, can absorb free protons inside the endosomes/
lysosomes leading to further H+-ATPase mediated-accumulation and 
increase in the membrane potential past the equilibrium level. This 
triggers chloride anions and water diffusion which further increases 
the osmotic pressure and concomitant endosome/lysosome swelling 
and rupture. On the other hand, the acidic environment inside the 
degradative compartments favors the dissociation of negatively charged 
nucleic acids or adenoviral particles from the positively charged PEI-
coated NPs allowing free DNA or RNA to reach the cytosol. 
Recent reports suggest that DNA-NPs complexes that are able to 
access the cytoplasm can be uptake by autophagosomes, due to an 
autophagic response of the cell leading to final degradation or a “long-
term” endosomal entrapment [58]. Although further experimentation 
is needed, we believe that this could be a possible scenario for our 
magneto-adenovectors as well. Re-capturing of free RAd-MNPs after 
endosome escape could explain the punctate perinuclear localization 
of fluorescent complexes 48 hours after the initial incubation mixture 
was removed and the occurrence of endosomal escape-autophagy 
uptake-autophagolysosome escape cycles could also contribute to a 
more prolonged presence of the RAd-MNPs complexes inside the cells, 
creating small “waves” of transgene release and expression, similar 
to a mini-pump system. We showed here that RAd-IGF1+PEIMag2 
could achieve longer expression that naked RAd as shown by IGF1 
levels measured at day 6 after gene delivery. Regardless of the exact 
mechanism that rules cell internalization and endosomal escape, 
we showed here that conjugation of recombinant adenovirus with 
PEIMag2 into magneto-adenovectors enhances viral gene delivery 
capability in hard-to-infect C2C12 myotubes, followed by an efficient 
transgene expression.
While in vitro magnetofection has become a highly successful 
technology for gene delivery in many different scenarios [1], in vivo 
applications still present themselves as a challenge. When applied to 
animal tissues, nanoparticle-based complexes encounter a significant 
set of barriers for penetration, mobility and distribution upon delivery 
[59]. Also, safety profile of NPs formulations needs to be in compliance 
with the requirements for biomedical usage. In the particular case 
of MNPs selection of an optimal external magnetic field is critical to 
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produce the desired migration (magnetophoresis) and distribution of 
magneto-adenovectors within the tissue. 
Despite many hurdles, magnetofection has been reported to 
enhance viral- or plasmid-mediated gene delivery into animal tissues 
like mouse brain [9,60,61], skeletal muscle [62], and liver tumors 
[63]. Here we describe how administration of magneto-adenoviral 
vectors followed by exposure to an external magnetic field was able to 
enhance transduction of soleus muscle in adult C57BL/6 mice. While 
naked RAd-GFP failed to transduce any muscle fiber, conjugation with 
Atto550PEI-Mag2 and subsequent exposure to an external magnetic 
field retrieved GFP+ myofibers 7 days later. Although magneto-
adenovectors were injected in the mid-belly of Soleus muscle, after 
magnetophoresis took place most of the RAd-MNPs complexes were 
localized in a small area beneath the muscle surface in close proximity 
to the original position of the external magnet. This phenomena could 
be due to a high intensity magnetic field and/or prolonged exposure 
time that generated enhanced strong attraction across the tissue. Similar 
findings were reported after magnetofection in skeletal muscle [62] and 
in an orthotopic rat hepatocellular carcinoma model [63] suggesting 
that further improvement is needed to achieve a fair homogeneous 
distribution throughout the magnetofected organ.
Conclusions
Development of reliable techniques for experimental manipulation 
of gene expression in mature skeletal muscle cells is critical to 
understand the molecular mechanisms involved in their physiology 
and pathophysiology. Magnetofection could serve as a powerful tool 
to aid Recombinant Adenoviral-mediated gene delivery into mature 
myofibers that are normally resistant to infection while preserving 
the benefits of these viral vectors. It is also worth noticing that other 
current uses of MNPs in vivo like cellular labeling, imaging modalities, 
drug delivery and magnetically induced hyperthermia [64] could 
benefit from any advances in the field.
Acknowledgements
The authors are grateful to Drs. R. Boland and C. Buitrago (Bahia Blanca, 
Argentina) for C2C12 cell line provision, to Dr. F. Sanchez and PhD students J.I. 
Schwerdt and L. Arciniegas (La Plata, Argentina) for technical assistance regarding 
magnetofection and magnetic fields and to Ms. R. Pereyra (La Plata, Argentina) for 
the illustrations. This work was supported by the National Institute of Health (NIH) 
grant R03TW008091 from the Fogarty International Center to Drs. O. Delbono 
and C. B. Hereñu, the Agencia Nacional de Promoción Cientifica y Tecnológica 
(ANPCYT) grant PICT08-2006 to Dr. Hereñu and the EU-German NEURONANO-
ELA 10/002 grant from the EULANEST to Dr. O. Mykhaylyk.
Author Contributions
ASP, OM and CBH designed the research; ASP, OM and CBH performed 
the experiments; ASP, OM, and CBH analyzed the data; ASP and CBH wrote the 
paper and OM, JRT, OD, RGG and CP contribute in selected paragraphs and final 
revision.
References
1. Plank C, Zelphati O, Mykhaylyk O (2011) Magnetically enhanced nucleic acid 
delivery. Ten years of magnetofection-progress and prospects. Adv Drug Deliv 
Rev 63: 1300-1331.
2. Widder KJ, Senyel AE, Scarpelli GD (1978) Magnetic microspheres: a model 
system of site specific drug delivery in vivo. Proc Soc Exp Biol Med 158: 141-
146.
3. Scherer F, Anton M, Schillinger U, Henke J, Bergemann C, et al. (2002) 
Magnetofection: enhancing and targeting gene delivery by magnetic force in 
vitro and in vivo. Gene Ther 9: 102-109.
4. Gupta AK, Gupta M (2005) Synthesis and surface engineering of iron oxide 
nanoparticles for biomedical applications. Biomaterials 26: 3995-4021.
5. Tresilwised N, Pithayanukul P, Holm PS, Schillinger U, Plank C, et al. (2012) 
Effects of nanoparticle coatings on the activity of oncolytic adenovirus-magnetic 
nanoparticle complexes. Biomaterials 33: 256-269.
6. Mykhaylyk O, Zelphati O, Hammerschmid E, Anton M, Rosenecker J, et al. 
(2009) Recent advances in magnetofection and its potential to deliver siRNAs 
in vitro. Methods Mol Biol 487: 111-146.
7. Zhao X, Cui H, Chen W, Wang Y, Cui B, et al. (2014) Morphology, structure and 
function characterization of PEI modified magnetic nanoparticles gene delivery 
system. PLoS One 9: e98919.
8. Oh N, Park JH (2014) Endocytosis and exocytosis of nanoparticles in 
mammalian cells. Int J Nanomedicine 9 Suppl 1: 51-63.
9. Sapet C, Pellegrino C, Laurent N, Sicard F, Zelphati O (2012) Magnetic 
nanoparticles enhance adenovirus transduction in vitro and in vivo. Pharm Res 
29: 1203-1218.
10. Choi JW, Park JW, Na Y, Jung SJ, Hwang JK, et al. (2015) Using a magnetic 
field to redirect an oncolytic adenovirus complexed with iron oxide augments 
gene therapy efficacy. Biomaterials 65: 163-174.
11. Lemieux P, Guérin N, Paradis G, Proulx R, Chistyakova L, et al. (2000) A 
combination of poloxamers increases gene expression of plasmid DNA in 
skeletal muscle. Gene Ther 7: 986-991.
12. Acsadi G, Jani A, Massie B, Simoneau M, Holland P, et al. (1994) A differential 
efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle 
cells of different maturity. Hum Mol Genet 3: 579-584.
13. Huard J, Lochmüller H, Acsadi G, Jani A, Holland P, et al. (1995) Differential 
short-term transduction efficiency of adult versus newborn mouse tissues by 
adenoviral recombinants. Exp Mol Pathol 62: 131-143.
14. Wickham TJ, Mathias P, Cheresh DA, Nemerow GR (1993) Integrins alpha 
v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus 
attachment. Cell 73: 309-319.
15. Tomko RP, Xu R, Philipson L (1997) HCAR and MCAR: the human and mouse 
cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. 
Proc Natl Acad Sci U S A 94: 3352-3356.
16. Nalbantoglu J, Pari G, Karpati G, Holland PC (1999) Expression of the primary 
coxsackie and adenovirus receptor is downregulated during skeletal muscle 
maturation and limits the efficacy of adenovirus-mediated gene delivery to 
muscle cells. Hum Gene Ther 10: 1009-1019.
17. Nalbantoglu J, Larochelle N, Wolf E, Karpati G, Lochmuller H, et al. (2001) 
Muscle-specific overexpression of the adenovirus primary receptor CAR 
overcomes low efficiency of gene transfer to mature skeletal muscle. J Virol 
75: 4276-4282.
18. Kimura E, Maeda Y, Arima T, Nishida Y, Yamashita S, et al. (2001) Efficient 
repetitive gene delivery to skeletal muscle using recombinant adenovirus 
vector containing the Coxsackievirus and adenovirus receptor cDNA. Gene 
Ther 8: 20-27.
19. Cao B, Pruchnic R, Ikezawa M, Xiao X, Li J, et al. (2001) The role of receptors 
in the maturation-dependent adenoviral transduction of myofibers. Gene Ther 
8: 627-637.
20. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, et al. (1990) Direct gene 
transfer into mouse muscle in vivo. Science 247: 1465-1468.
21. Gao X, Huang L (1995) Cationic liposome-mediated gene transfer. Gene Ther 
2: 710-722.
22. Sandri M, Bortoloso E, Nori A, Volpe P (2003) Electrotransfer in differentiated 
myotubes: a novel, efficient procedure for functional gene transfer. Exp Cell 
Res 286: 87-95.
23. Wang Y, Fraefel C, Protasi F, Moore RA, Fessenden JD, et al. (2000) HSV-1 
amplicon vectors are a highly efficient gene delivery system for skeletal muscle 
myoblasts and myotubes. Am J Physiol Cell Physiol 278: C619-626.
24. Sapru MK, McCormick KM, Thimmapaya B (2002) High-efficiency adenovirus-
mediated in vivo gene transfer into neonatal and adult rodent skeletal muscle. 
J Neurosci Methods 114: 99-106.
25. Sanchez-Antequera Y, Mykhaylyk O, Thalhammer S, Plank C (2010) Gene 
delivery to jurkat t cells using non-viral vectors associated with magnetic 
nanoparticles. International Journal of Biomedical Nanoscience and 
Nanotechnology 1: 202-229. 
26. Mykhaylyk O, Antequera YS, Vlaskou D, Plank C (2007) Generation of 
Citation: Pereyra AS, Mykhaylyk O, Lockhart EF, Taylor JR, Delbono O, et al. (2016) Magnetofection Enhances Adenoviral Vector-based Gene 
Delivery in Skeletal Muscle Cells. J Nanomed Nanotechnol 7: 364. doi:10.4172/2157-7439.1000364
Page 11 of 11
J Nanomed Nanotechnol
ISSN: 2157-7439 JNMNT, an open access journal
Volume 7 • Issue 2 • 1000364
magnetic nonviral gene transfer agents and magnetofection in vitro. Nat Protoc 
2: 2391-2411.
27. Vlaskou D, Plank C, Mykhaylyk O (2013) Magnetic and acoustically active 
microbubbles loaded with nucleic acids for gene delivery. Methods Mol Biol 
948: 205-241.
28. Bett AJ, Haddara W, Prevec L, Graham FL (1994) An efficient and flexible 
system for construction of adenovirus vectors with insertions or deletions in 
early regions 1 and 3. Proceedings of the National Academy of Sciences of the 
United States of America 91: 8802-6. 
29. Daughaday WH, Rotwein P (1989) Insulin-like growth factors I and II. 
Peptide, messenger ribonucleic acid and gene structures, serum, and tissue 
concentrations. Endocr Rev 10: 68-91.
30. Mykhaylyk OLD, Vlaskou D, Schoemig V, Detloff T, Krause D, et al. (2015) 
Magnetophoretic mobility: Determination by space and time resolved extinction 
profiles (in-situ visualization). 
31. Wilhelm C, Gazeau F, Bacri JC (2002) Magnetophoresis and ferromagnetic 
resonance of magnetically labeled cells. Eur Biophys J 31: 118-125.
32. Breier BH, Gallaher BW, Gluckman PD (1991) Radioimmunoassay for 
insulin-like growth factor-I: solutions to some potential problems and pitfalls. J 
Endocrinol 128: 347-357.
33. Fraker PJ, Speck JC Jr (1978) Protein and cell membrane iodinations with 
a sparingly soluble chloroamide 3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. 
Biochemical and biophysical research communications 80: 849-57. 
34. Shimatsu A, Rotwein P (1987) Mosaic evolution of the insulin-like growth 
factors. Organization, sequence, and expression of the rat insulin-like growth 
factor I gene. J Biol Chem 262: 7894-7900.
35. Lee PD, Baker BK, Liu F, Kwan EY, Hintz RL (1996) A homologous 
radioimmunoassay for rat insulin-like growth factor-I (IGF-I): implications for 
studies of human IGF-I physiology. J Clin Endocrinol Metab 81: 2002-2005.
36. Akiyama H, Ito A, Kawabe Y, Kamihira M (2010) Genetically engineered 
angiogenic cell sheets using magnetic force-based gene delivery and tissue 
fabrication techniques. Biomaterials 31: 1251-1259.
37. Goldspink G (2003) Skeletal muscle as an artificial endocrine tissue. Best 
practice and research Clinical endocrinology & metabolism 17: 211-22. 
38. Prijic S, Scancar J, Romih R, Cemazar M, Bregar VB, et al. (2010) Increased 
cellular uptake of biocompatible superparamagnetic iron oxide nanoparticles 
into malignant cells by an external magnetic field. J Membr Biol 236: 167-179.
39. Gu J, Xu H, Han Y, Dai W, Hao W, et al. (2011) The internalization pathway, 
metabolic fate and biological effect of superparamagnetic iron oxide 
nanoparticles in the macrophage-like raw 264.7 cell. Science China Life 
sciences 54: 793-805. 
40. Poussard S, Decossas M, Le Bihan O, Mornet S, Naudin G, et al. (2015) 
Internalization and fate of silica nanoparticles in C2C12 skeletal muscle cells: 
evidence of a beneficial effect on myoblast fusion. Int J Nanomedicine 10: 
1479-1492.
41. Zhang S, Gao H, Bao G (2015) Physical Principles of Nanoparticle Cellular 
Endocytosis. ACS Nano 9: 8655-8671.
42. Ma Y, Zhang Z, Wang X, Xia W, Gu H (2011) Insights into the mechanism of 
magnetofection using MNPs-PEI/pDNA/free PEI magnetofectins. Int J Pharm 
419: 247-254.
43. Huth S, Lausier J, Gersting SW, Rudolph C, Plank C, et al. (2004) Insights into 
the mechanism of magnetofection using PEI-based magnetofectins for gene 
transfer. J Gene Med 6: 923-936.
44. Akinc A, Battaglia G (2013) Exploiting endocytosis for nanomedicines. Cold 
Spring Harb Perspect Biol 5: a016980.
45. Billiet L, Gomez JP, Berchel M, Jaffrès PA, Le Gall T, et al. (2012) Gene 
transfer by chemical vectors, and endocytosis routes of polyplexes, lipoplexes 
and lipopolyplexes in a myoblast cell line. Biomaterials 33: 2980-2990.
46. Chorny M, Polyak B, Alferiev IS, Walsh K, Friedman G, et al. (2007) Magnetically 
driven plasmid DNA delivery with biodegradable polymeric nanoparticles. 
FASEB journal: official publication of the Federation of American Societies for 
Experimental Biology 21: 2510-2519. 
47. Zeng X, Zhang Y, Nyström AM (2012) Endocytic uptake and intracellular 
trafficking of bis-MPA-based hyperbranched copolymer micelles in breast 
cancer cells. Biomacromolecules 13: 3814-3822.
48. Maiolino S, Russo A, Pagliara V, Conte C, Ungaro F, et al. (2015) 
Biodegradable nanoparticles sequentially decorated with Polyethyleneimine 
and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells. J 
Nanobiotechnology 13: 29.
49. Bregar VB, Lojk J, Suštar V, Veranič P, Pavlin M (2013) Visualization of 
internalization of functionalized cobalt ferrite nanoparticles and their intracellular 
fate. Int J Nanomedicine 8: 919-931.
50. Kloeckner J, Boeckle S, Persson D, Roedl W, Ogris M, et al. (2006) DNA 
polyplexes based on degradable oligoethylenimine-derivatives: Combination 
with egf receptor targeting and endosomal release functions. Journal of 
controlled release: official journal of the Controlled Release Society 116: 115-
22. 
51. Chang KL, Higuchi Y, Kawakami S, Yamashita F, Hashida M (2010) Efficient 
gene transfection by histidine-modified chitosan through enhancement of 
endosomal escape. Bioconjug Chem 21: 1087-1095.
52. Meier O, Boucke K, Hammer SV, Keller S, Stidwill RP, et al. (2002) Adenovirus 
triggers macropinocytosis and endosomal leakage together with its clathrin-
mediated uptake. J Cell Biol 158: 1119-1131.
53. Meier O, Greber UF (2004) Adenovirus endocytosis. J Gene Med 6 Suppl 1: 
S152-163.
54. Bakhru SH, Altiok E, Highley C, Delubac D, Suhan J, et al. (2012) Enhanced 
cellular uptake and long-term retention of chitosan-modified iron-oxide 
nanoparticles for MRI-based cell tracking. Int J Nanomedicine 7: 4613-4623.
55. Gujrati M, Malamas A, Shin T, Jin E, Sun Y, et al. (2014) Multifunctional cationic 
lipid-based nanoparticles facilitate endosomal escape and reduction-triggered 
cytosolic siRNA release. Mol Pharm 11: 2734-2744.
56. Wang F, Zhang W, Shen Y, Huang Q, Zhou D, et al. (2015) Efficient RNA 
delivery by integrin-targeted glutathione responsive polyethyleneimine capped 
gold nanorods. Acta Biomater 23: 136-146.
57. Behr J-P (1997) The proton sponge: A trick to enter cells the viruses did not 
exploit. CHIMIA International Journal for Chemistry 51: 34-36. 
58. Remaut K, Oorschot V, Braeckmans K, Klumperman J and De Smedt SC (2014) 
Lysosomal capturing of cytoplasmic injected nanoparticles by autophagy: An 
additional barrier to non viral gene delivery. Journal of controlled release : 
official journal of the Controlled Release Society 195: 29-36. 
59. Lane LA, Qian X, Smith AM, Nie S (2015) Physical chemistry of nanomedicine: 
understanding the complex behaviors of nanoparticles in vivo. Annu Rev Phys 
Chem 66: 521-547.
60. Soto-Sánchez C, Martínez-Navarrete G, Humphreys L, Puras G, Zarate J, et 
al. (2015) Enduring high-efficiency in vivo transfection of neurons with non-
viral magnetoparticles in the rat visual cortex for optogenetic applications. 
Nanomedicine 11: 835-843.
61. Hashimoto M, Hisano Y (2011) Directional gene-transfer into the brain by an 
adenoviral vector tagged with magnetic nanoparticles. J Neurosci Methods 
194: 316-320.
62. Zhou XF, Liu B, Yu XH, Zha X, Zhang XZ, et al. (2007) Using magnetic force to 
enhance immune response to DNA vaccine. Small 3: 1707-1713.
63. Almstätter I, Mykhaylyk O, Settles M, Altomonte J, Aichler M, et al. (2015) 
Characterization of magnetic viral complexes for targeted delivery in oncology. 
Theranostics 5: 667-685.
64. Lee JH, Kim JW, Cheon J (2013) Magnetic nanoparticles for multi-imaging and 
drug delivery. Mol Cells 35: 274-284.
Citation: Pereyra AS, Mykhaylyk O, Lockhart EF, Taylor JR, Delbono O, et 
al. (2016) Magnetofection Enhances Adenoviral Vector-based Gene Delivery 
in Skeletal Muscle Cells. J Nanomed Nanotechnol 7: 364. doi:10.4172/2157-
7439.1000364
